Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

Choose the language:

  Homepage
Continue on the current website:  

 

icobrain

icobrain is intended for automatic labeling visualization and volumetric quantification of segmentable brain structures from a set of MR or noncontrast CT (NCCT) images.

Inquire Now

Ico Metrix
  • MR
  • MRI
  • CT
  • volumetric quantification
  • AI
  • segmentation
  • multiple sclerosis
  • dementia
  • TBI
  • traumatic brain injury

Automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR and NCCT (non-contrast CT) images.

The output of each icobrain evaluation consists of a concise report with normative reference values and color-coded segmentations in DICOM format to help the radiologist and neurologist interpret and communicate the patient's condition.

Yellow arrow

Augmented productivity due to 60% faster reporting1

1Sima, D; Wilms, G; Vande Vyvere, T; Van Hecke, W; Smeets, D; Leuven/BE; Leuven, Be/BE; icometrix, Belgium/BE; Not applicable, Retrospective, Image verification, Computer Applications-Detection, diagnosis, MR, Neuroradiology brain, Artificial Intelligence and Machine Learning, Multicentre study; ECR 2020. Retrieved March 27, 2023 from https://epos.myesr.org/poster/esr/ecr2020/C-11342

Yellow arrow

Increases consistency

icobrain ms structured report increases consistency (reduced intra rater variablity among assistant neurologists)1,2

1Struyfs H, Sima DM, Wittens M, Ribbens A, Pedrosa de Barros N, Phan TV, Ferraz Meyer MI, Claes L, Niemantsverdriet E, Engelborghs S, Van Hecke W, Smeets D. Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm. Neuroimage Clin. 2020;26:102243. doi: 10.1016/j.nicl.2020.102243. Epub 2020 Mar 12. PMID: 32193172; PMCID: PMC7082216.

2Sima, D; Wilms, G; Vande Vyvere, T; Van Hecke, W; Smeets, D; Leuven/BE; Leuven, Be/BE; icometrix, Belgium/BE; Not applicable, Retrospective, Image verification, Computer Applications-Detection, diagnosis, MR, Neuroradiology brain, Artificial Intelligence and Machine Learning, Multicentre study; ECR 2020. Retrieved March 27, 2023 from https://epos.myesr.org/poster/esr/ecr2020/C-11342

 

    icobrain DM

    icobrain DM

    icobrain DM for MR and CT

    icobrain dm is intended to automate the current manual process of identifying, labeling, and quantifying the volume of segmentable brain structures identified on MR or NCCT images. For MR images icobrain dm uncovers abnormality patterns by 1) Assessing the total FLAIR lesion burden and 2) Comparing whole brain and ventricular volumes to an age-and gender matched normative healthy population. For NCCT images icobrain dm uncovers abnormality patterns by comparing whole brain and ventricular volumes to an age- and gender matched normative healthy population.

    icobrain MS

    icobrain MS

    icobrain ms: Cloud-based Al solution to help MS care teams deliver personalized care for patients with multiple sclerosis.

    This application is an Al solution for the volumetric quantification of brain MRI scans in clinical practice.

    • Population graph shows the ageand gender-matched median and normal range for the whole brain and gray matter volume of healthy people. 
    • Apply treatment scoring in routine (Rio, NEDA-3, NEDA-4, Rio-4) 
    • Exercise Shared Decision Making 
    • Assess treatment adherence
    icobrain TBI

    icobrain TBI

    icobrain TBI for MR and CT

    icobrain tbi produces reports that can be useful when evaluating potential traumatic brain injury patients. For MR images icobrain TBI uncovers abnormality patterns by 1) Detecting and quantifying FLAIR white matter hyperintensities and 2) Comparing brain volumes to an age and gender matched normative healthy population. For NCCT images icobrain TBI allows for the detection of mass effects by: 1) Detecting, quantifying and classifying hyperdensities (epidural, subdural and intra­ parenchymal). 2) Assessing the CSF spaces (ventricular and cisternal spaces) and ventricular asymmetry. 3) Measuring midline shift. 4) Visualizing CSF space patterns in an intuitive bull's eye graph. 5) Comparing volumes to an age-and gender matched normative healthy population

     

    References

    References

    1. lcometrix HCP Manual icobrian MR 5.0.5x doc. 158313995.45
    2. icometrix Manual - Report Interpretation
    3. FDA premarket notification K192130
    4. Sima et al, ECR 2020, Poster C-11342 RESULTS
    5. Van Hecke et al, Novel Digital Care Management Platform in MS, Brain Sci, 2021

    What Customers Are Saying

    "icobrain provides reliable MRI analysis allowing me to instantly track the disease progression of our patients with a neurological disorder."

    Vitazoslav Belan, Dr Magnet Kramare,
    at Pro Diagnostic Group, Slovakia

    May not reflect a typical user experience; actual results may vary.

    What Customers Are Saying

    "We use icobrain for quantifying lesions on our routine MRIs. In this work, the analysis of icometrix serves as an unbiased second opinion."

    Mrs. Shilpa
    Neuroradiologist at Picture This by Jankharia Imaging Center India

    May not reflect a typical user experience; actual results may vary.

    What Customers Are Saying

    "Like icobrain, brain biomarker measurements need to be extremely reproducible and sensitive enough to detect relevant clinical changes."

    Dr. Max Wintermark
    Professor of Radiology and Chief of Neuroradiology at Stanford University Medical Center USA

    May not reflect a typical user experience; actual results may vary.

    What Customers Are Saying

    "I feel like icobrain's AI is better at diagnosing hippocampal loss compared to visual rating. Whilst with the volumetric report, we clearly see a hippocampal loss, we could not identify this by visual assessment (MTA-score)."

    De Roeck
    MD Radiologist at AZ Herentals

    May not reflect a typical user experience; actual results may vary.

    What Customers Are Saying

    "icobrain ms has been a really valuable addition to our clinical practice as patients can conceptually understand much better what we are looking for in their brain scans."

    Jeffrey Dunn,
    MD, MS Neurologist

    May not reflect a typical user experience; actual results may vary.

    Request a demo

    See Ahead for Yourself

     

    Inquire now
    LinkedIn LinkedIn

    © 2022, 2023 Bayer

    The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

    BAYER, the Bayer Cross, Radimetrics and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.

    This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

     

    Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.

     

    You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

    Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

     

    Bayer U.S. | Digital Solutions, 100 Bayer Blvd., Whippany, NJ 07981-0915

     

    Last Updated: September 2023

    © 2022, 2023, 2024 Bayer

    The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

    BAYER, the Bayer Cross, Radimetrics and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.

    This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

     

    Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.

     

    You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

    Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

     

    Bayer U.S. | Digital Solutions, 100 Bayer Blvd., Whippany, NJ 07981-0915

     

    Last Updated: December 2024

    Bayer Logo